Parkinson's disease decisions — 2025

The Board denied service connection for Parkinson's disease and denied increased ratings for various peripheral neuropathies, except granted a 20 percent rating from April 21, 2019, for left lower extremity peripheral neuropathy and a 30 percent rating for right lower extremity peripheral neuropathy. The Board also granted service connection for PTSD effective April 21, 2019, and awarded TDIU from that date.

The Board denied the veteran's claims for increased ratings and effective dates, as well as remanded several issues related to Parkinson's disease and associated conditions.

The Board granted service connection for hypertension, PTSD, and peripheral neuropathy of the upper and lower extremities effective March 29, 2022. The claim for a back condition was remanded for further development.

The Board granted a 100 percent disability rating for neurocognitive disorder associated with progressive supranuclear palsy with parkinsonism and granted special monthly compensation based on the regular need for aid and attendance due to both conditions.

The Board denied higher ratings for hypothyroidism and Parkinson's Disease residuals, but granted earlier effective dates for some service-connected conditions.

The Board denied increased ratings for several service-connected conditions and granted an earlier effective date for one condition, but also remanded claims related to Parkinson's disease and certain SMC and DEA issues.

The Board remands the matter for further development, including obtaining unit morning reports and treatment records from a neurologist.

The Board denied an initial rating higher than 10 percent for coronary artery disease and remanded several issues, but granted special monthly compensation at the intermediate rate effective February 24, 2014.

The Board granted service connection for Parkinsonism and/or Parkinson's disease, which is presumed related to in-service herbicide agent exposure under the PACT Act. The claim for an acquired psychiatric disability was denied.

The Board denied the veteran's claims for earlier effective dates and higher ratings for various service-connected conditions, except for a separate 30% rating for Parkinson's disease with right upper extremity tremor and a separate 20% rating for right lower extremity tremor.

The Board granted service connection for depression as secondary to Parkinson's disease and Parkinson's disease itself, both related to the Veteran's military service. The claims for COPD, OSA, and a higher level of special monthly compensation were remanded.

The Board granted service connection for obstructive sleep apnea and remanded several other claims, including those for essential tremors (parkinsonism), psychiatric disability, hypothyroidism, hearing loss, ischemic heart disease, pulmonary/ respiratory disability, blood clots, and aortic aneurysm.

The Board denied earlier effective dates for the grant of service connection for various Parkinson's disease residuals, except for speech changes and constipation which were granted an effective date of July 3, 2019. SMC based on the need for regular aid and attendance was also granted.

The Board denied a rating greater than 30 percent for the Veteran's cervical strain with degenerative arthritis and intervertebral disc syndrome, but granted a 40 percent rating for left upper extremity radiculopathy and a 30 percent rating for right upper extremity radiculopathy. The claims for service connection for a Parkinson's-like condition, earlier effective dates, and TDIU were denied.

The Board granted an earlier effective date of May 2, 2019, for the grant of service connection for Parkinson's disease.

The Board granted an effective date of October 26, 2023, for service connection of Parkinsonism, with major depression, neurocognitive disorder, dementia, and insomnia disorder.

All appeals were withdrawn by the Veteran's representative prior to the Board's decision, and therefore, the appeal is dismissed.

The Board remands the claim for additional development, including obtaining outstanding treatment records from various providers.

The Board remands the claim for a new VA examination to determine whether the Veteran has Parkinsonism or if there is a nexus between any 'Parkinson's-like' or 'Parkinsonism-like' symptoms and in-service herbicide exposure.

The Board denied service connection for Parkinson's disease, parkinsonism, and peripheral neuropathy in the upper and lower extremities as there was no evidence of exposure to herbicide agents during active service or sufficient evidence linking these conditions to service.